The total return over the past 12 months is -10.16% vs. +16.94% for the S&P 500. So far it's up +7.00% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (10.16%) | (29.38%) | (28.16%) | (10.66%) | (1.80%) | (1.93%) |
| Total Return CAGR | (10.16%) | (29.38%) | (28.16%) | (10.66%) | (1.80%) | (1.93%) |
| Revenue CAGR | +1.60% | +2.16% | +1.77% | +5.62% | +5.34% | +8.55% |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +20.37% | (25.70%) | (22.76%) | (2.32%) | (1.31%) | +2.34% |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Integra LifeSciences Holdings Corporation (IART)
| Year | Start price | End price | IART Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $12.42 | $13.29 | +7.00% | +14.51% | (7.51%) |
| 2025 | $22.68 | $12.42 | (45.24%) | +17.72% | (62.96%) |
| 2024 | $43.55 | $22.68 | (47.92%) | +24.89% | (72.81%) |
| 2023 | $56.07 | $43.55 | (22.33%) | +26.19% | (48.52%) |
| 2022 | $66.99 | $56.07 | (16.30%) | (18.17%) | +1.87% |
| 2021 | $64.92 | $66.99 | +3.19% | +28.74% | (25.55%) |
| 2020 | $58.28 | $64.92 | +11.39% | +18.37% | (6.98%) |
| 2019 | $45.10 | $58.28 | +29.22% | +31.22% | (2.00%) |
| 2018 | $47.86 | $45.10 | (5.77%) | (4.56%) | (1.21%) |
| 2017 | $42.90 | $47.86 | +11.57% | +21.70% | (10.13%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
